XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information
6 Months Ended
Jun. 30, 2020
Business Segment Information  
Business Segment Information

NOTE C—Business Segment Information

The accounting policies of the Company’s segments are the same as those described in Note A—“General.” The Company evaluates performance of its segments based on profit or loss from operations before stock compensation expense, depreciation and amortization, interest expense, interest and other income, changes in the fair value of contingent consideration recorded in relation to acquisitions, gain on sale of assets, special charges or benefits, and income taxes (“Segment Profit”). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Healthcare subcontracts with Pharmacy Management to provide pharmacy benefits management services for certain of Healthcare’s customers. In addition, Pharmacy Management provides pharmacy benefits management for the Company’s employees covered under its medical plan. As

such, revenue, cost of goods sold and direct service costs and other related to these arrangements are eliminated. The Company’s segments are defined in Note A—“General.”

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

    

Healthcare

    

Management

    

Elimination

    

Consolidated

 

Three Months Ended June 30, 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

546,113

​

$

62,648

​

$

(147)

​

$

608,614

​

PBM revenue

​

 

—

​

 

550,010

​

 

(4,335)

​

 

545,675

​

Cost of care

​

 

(408,911)

​

 

—

​

 

—

​

 

(408,911)

​

Cost of goods sold

​

 

—

​

 

(505,203)

​

 

4,122

​

 

(501,081)

​

Direct service costs and other

​

 

(98,314)

​

 

(78,776)

​

 

(18,817)

​

 

(195,907)

​

Stock compensation expense (1)

​

 

2,237

​

 

2,124

​

 

846

​

 

5,207

​

Segment Profit (Loss)

​

$

41,125

​

$

30,803

​

$

(18,331)

​

$

53,597

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

​

​

​

​

​

​

Pharmacy

​

and

​

​

​

​

​

    

Healthcare

    

Management

    

Elimination

    

Consolidated

​

Three Months Ended June 30, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

481,021

​

$

67,867

​

$

(177)

​

$

548,711

​

PBM revenue

​

 

—

​

 

556,195

​

 

(4,831)

​

 

551,364

​

Cost of care

​

 

(321,831)

​

 

—

​

 

—

​

 

(321,831)

​

Cost of goods sold

​

 

—

​

 

(532,685)

​

 

4,618

​

 

(528,067)

​

Direct service costs and other

​

 

(100,450)

​

 

(80,082)

​

 

(19,224)

​

 

(199,756)

​

Stock compensation expense (1)

​

 

2,102

​

 

1,939

​

 

2,551

​

 

6,592

​

Segment Profit (Loss)

​

$

60,842

​

$

13,234

​

$

(17,063)

​

$

57,013

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

​

Healthcare

​

Management

​

Elimination

​

Consolidated

 

Six Months Ended June 30, 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

1,052,935

​

$

122,543

​

$

(316)

​

$

1,175,162

​

PBM revenue

​

 

—

​

 

1,106,575

​

 

(8,442)

​

 

1,098,133

​

Cost of care

​

 

(778,008)

​

 

—

​

 

—

​

 

(778,008)

​

Cost of goods sold

​

 

—

​

 

(1,035,410)

​

 

8,015

​

 

(1,027,395)

​

Direct service costs and other (1)

​

 

(198,424)

​

 

(158,411)

​

 

(41,372)

​

 

(398,207)

​

Stock compensation expense (1)

​

 

3,780

​

 

3,796

​

 

7,031

​

 

14,607

​

Segment Profit (Loss)

​

$

80,283

​

$

39,093

​

$

(35,084)

​

$

84,292

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

​

Healthcare

​

Management

​

Elimination

​

Consolidated

 

Six Months Ended June 30, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

969,927

​

$

132,302

​

$

(350)

​

$

1,101,879

​

PBM revenue

​

 

—

​

 

1,129,973

​

 

(9,398)

​

 

1,120,575

​

Cost of care

​

 

(670,939)

​

 

—

​

 

—

​

 

(670,939)

​

Cost of goods sold

​

 

—

​

 

(1,070,259)

​

 

8,951

​

 

(1,061,308)

​

Direct service costs and other (1)

​

 

(206,386)

​

 

(161,948)

​

 

(35,663)

​

 

(403,997)

​

Stock compensation expense (1)

​

 

3,863

​

 

4,046

​

 

4,480

​

 

12,389

​

Segment Profit (Loss)

​

$

96,465

​

$

34,114

​

$

(31,980)

​

$

98,599

​

​

(1)Stock compensation expense, changes in the fair value of contingent consideration recorded in relation to acquisitions and impairment of intangible assets are included in direct service costs and other operating expenses; however, these amounts are excluded from the computation of Segment Profit.

The following table reconciles income from continuing operations before income taxes to Segment Profit from continuing operations (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

​

June 30, 

​

June 30, 

​

​

​

2019

    

2020

    

2019

    

2020

​

Income from continuing operations before income taxes

​

$

12,950

​

$

10,780

​

$

1,550

​

$

15,472

​

Stock compensation expense

​

 

5,207

​

 

6,592

​

 

14,607

​

 

12,389

​

Depreciation and amortization

​

 

28,191

​

 

23,888

​

 

53,608

​

 

47,246

​

Interest expense

​

 

9,070

​

 

7,995

​

 

18,107

​

 

16,953

​

Interest and other income

​

 

(1,821)

​

 

(551)

​

 

(3,580)

​

 

(1,770)

​

Special charges

​

​

—

​

​

8,309

​

​

—

​

​

8,309

​

Segment Profit from continuing operations

​

$

53,597

​

$

57,013

​

$

84,292

​

$

98,599

​

​